The above-mentioned would be an explanation for the use of prolactin lowering medication in infertile patients with endometriosis and hyperprolactinaemia, but well-controlled clinical studies including an adequate number of infertile patients with an association of hyperprolactinaemia and endometriosis are still missing. This evidence concerns the gene PRL and hyperpituitarism.